Literature DB >> 11325366

The treatment of impending and existing pathological femoral fractures using the long gamma nail.

S A Edwards1, H G Pandit, H J Clarke.   

Abstract

The subtrochanteric region of the femur accounts for one-third of all pathological fractures requiring surgical intervention. The large forces occurring in this region and the possible non-occurrence of bony consolidation constitute a difficult problem to the trauma surgeon. The medical records and X-rays of 25 consecutive patients treated with the long gamma nail (LGN) for pathological (impending or existing) fractures of the femur were analysed retrospectively. Our results in the use of the LGN for pathological fractures of the femur have been good. We recommend an aggressive approach to the early stabilisation of impending fractures and the use of distal locking.

Entities:  

Mesh:

Year:  2001        PMID: 11325366     DOI: 10.1016/s0020-1383(00)00218-7

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Subtrochanteric metastatic lesions treated with the long gamma nail.

Authors:  S R Samsani; V Panikkar; D Georgiannos; D Calthorpe
Journal:  Int Orthop       Date:  2003-06-11       Impact factor: 3.075

2.  Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome.

Authors:  Bill Ristevski; Richard J Jenkinson; David J G Stephen; Joel Finkelstein; Emil H Schemitsch; Michael D McKee; Hans J Kreder
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

3.  Is There an Association Between Prophylactic Femur Stabilization and Survival in Patients with Metastatic Bone Disease?

Authors:  Travis C Philipp; Jacob D Mikula; Yee-Cheen Doung; Kenneth R Gundle
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

Review 4.  Prevention of Pathological Fracture of the Proximal Femur: A Systematic Review of Surgical and Percutaneous Image-Guided Techniques Used in Interventional Oncology.

Authors:  Laëtitia Rodrigues; François H Cornelis; Nicolas Reina; Sylvie Chevret
Journal:  Medicina (Kaunas)       Date:  2019-11-22       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.